In The News Posted January 10, 2020 Share Posted January 10, 2020 SAN DIEGO, Jan. 10, 2020 /PRNewswire/ -- Companion Medical, Inc., an innovative diabetes company that developed the first and only FDA-cleared smart insulin pen and app system, today announced that it has entered into a loan and security agreement for up to $27.5 million with K2... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.